Features of electron microscopic changes in the liver of rats aged 24-26 months under conditions of hyperhomocysteinemia
Disruption of the metabolism of the essential amino acid methionine causes the syndrome of hyperhomocysteinemia. This pathological condition is associated with the risk of developing a number of diseases, including chronic liver disease. The mechanisms of liver tissue damage in hyperhomocysteinemia remain poorly understood and require more detailed study. The aim of the study is to establish the features of submicroscopic changes in the liver structure of old rats with hyperhomocysteinemia. The experimental study was performed on 22 white nonlinear old (24-26 months) male rats, which were divided into a control group and an experimental group. A model of persistent hyperhomocysteinemia was created by administering to rats of experimental group of thiolactone homocysteine at a dose of 200 mg/kg body weight intragastrically for 60 days. The study of ultrastructural changes in the lungs of rats was performed using an electron microscope PEM-125K. At experimental hyperhomocysteinemia in a liver of old rats there are changes in all structural components. Mitochondrial destruction and edema were observed in the vascular endothelium. Organelles have an enlightened matrix, a reduced number of cristae. A significant content of destructively altered mitochondria in endothelial cells indicates a failure of adaptation mechanisms. Erythrocyte sludges are observed in the lumens of the sinusoids. The number of fat-accumulating cells decreases, which indicates their transformation into fibroblasts and leads to the growth of collagen fibers, expansion of the sinusoidal spaces and the development of stromal fibrosis.
 Drapkyna, O. V., Deeva, T. A., & Yvashkyn, V. T. (2015). Evaluation of endothelial function and the degree of apoptosis in patients with metabolic syndrome and non-alcoholic fatty liver disease. Therapeutic archive, (5), 76-83.
 Grechanyna, O. Ya. (2013). Methionine – an essential amino acid. Clinical genetics and perinatal diagnosis, 1(2), 19-35.
 Horalskyi, L. P., Khomych, V. T., & Kononskyi, O. I. (2011). Fundamentals of histological technique and morphofunctional research methods in normal and pathology. Zhytomyr: Polissya.
 Jacobs, R. L., Jiang, H., Kennelly, J. P., Orlicky, D. J., Allen, R. H., Stabler, S. P., … & Maclean, K. N. (2017). Cystathione beta-synthase deficiency alters hepatic phospholipid and choline metabolism: post-translation repression of phosphatidylethanolamine N-methyltransferase is a consequence rather than a cause of liver injury in homocysteinuria. Mol Genet Metab, 120(4), 325-336. doi: 10.1016/j.ymgme.2017.02.010
 Korzhevskyi, D. E., & Gyliarov, A. V. (2010). Basics of histological technique. SPb: SpecLit.
 Kychyhyna, O. N., Golubeva, T. I., Troshyna, I. A., & Romanova, N. V. (2015). Pathogenetic significance of hyperhomocysteinemia in non-alcoholic fatty liver disease. Medical science and education of the Urals, 3(83), 177-182.
 Lutsiuk, M. B., Zaichko, N. V., Hryhorieva, G. S., Konakhovych, M. A., Artemchuk, M. A., Pentiuk, N. O., & Postovitenko, K. P. (2013). Hyperhomocysteinemia syndrome: causes, methods of prevention and treatment. Rational pharmacotherapy, 29(4), 55-60.
 Medvedev, D. V., Zviahyna, V. I., & Fomyna, M. A. (2014). Method for modeling severe hyperhomocysteinemia in rats. Russian medical and biological bulletin named after academician I. P. Pavlov, (4), 42-46.
 Pentiuk, N. O. (2010). Activation of hepatic fibrogenesis under conditions of high-fat diet in rats. The role of hyperhomocysteinemia and vasoactive mediators. Bulletin of problems of biology and medicine, (1), 164-169.
 Pentiuk, N. O. (2010). Hyperhomocysteinemia in patients with chronic hepatitis and liver cirrhosis. Relationship with the supply of vitamins B6, B9, B12 and the severity of the disease. Bulletin of problems of biology and medicine, (3), 171-176.
 Pentiuk, N. O., & Korol, A. P. (2009). Morphological aspects of the influence of hyperhomocysteinemia on hepatic fibrogenesis in rats. Bulletin of Vinnytsia National Medical University, 13(2), 460-465.
 Skovierova, H., Vidomanova, E., Mahmood, S., Sopkova, J., Drgova, A., Cervenova, T., … & Lehotsky, J. (2016). The molecular and cellular effect of homocysteine metabolism imbalance on human health. Int J Mol Sci, 17(10), 1733. doi: 10.3390/ijms17101733
 Sreckovic, B., Sreckovic, V. D., Solatovic, I., Colak, E., Sumarac-Dumanovic, M., Janeski, H., … & Mrdovic, I. (2017). Homocysteine is a marker for metabolic syndrome and atherosclerosis. Diabetes Metab Syndr, 11(3), 179-182. doi: 10.1016/j.dsx.2016.08.026
 Vlasenko, A. V. (2013). The effect of hyperhomocysteinemia on the development of non-alcoholic fatty liver disease in diabetes mellitus. International Endocrinological Journal, 1(49), 10-14.
 Wang, H., Sun, Q., Zhou, Y., Zhang, H., Luo, C., Xu, J., … & Wang, W. (2017). Nitration-mediated deficiency of cystathione β-synthase activity accelerates the progression of hyperhomocysteinemia. Free Radic Biol Med, (113), 519-529. doi: 10.1016/j.freeradbiomed.2017.10.389
 Zaichko, N. V. (2010). Processes of methylation, transsulfation, metabolism of cysteine and adenosine in the liver of rats in acute methionine hyperhomocysteinemia and its correction by a complex of vitamins B6, B9, B12. Bulletin of problems of biology and medicine, (2), 73-79.
 Zaric, B. L., Obradovic, M., Bajic, V., Haidara, M. A., Jovanovic, M., & Isenovic, E. R. (2019). Homocysteine and hyperhomocysteinaemia. Current medicinal chemistry, 26(16), 2948-2961. doi: 10.2174/0929867325666180313105949
 Zobova, D. A., & Kozlov, S. A. (2016). The role of homocysteine in the pathogenesis of certain diseases. Medical sciences, 3(39), 132-144.
 Zviahyntseva, T. D., Chernobai, A. I., & Glushchenko, S. V. (2014). The role of ademetionine in the development and progression of chronic liver diseases. Ukrainian medical journal, 3(101), 56-59.
This work is licensed under a Creative Commons Attribution 4.0 International License.